Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

US FDA approves 1st oral pill for postpartum depression

Tags: pill

Manufactured by Sage Therapeutics and Biogen, Zurzuvae (zuranolone) has been approved as a once-daily Pill (50mg) to be taken for 14 days. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy. To date, treatment for PPD was only available as an IV injection […]



This post first appeared on Business News, please read the originial post: here

Share the post

US FDA approves 1st oral pill for postpartum depression

×

Subscribe to Business News

Get updates delivered right to your inbox!

Thank you for your subscription

×